Camber Capital Management LP
Last filed Aug 14, 2025
Inactive · not filing 13F
$1.07B
23
-$767M
53.2%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2025 | |||||
 ZBH | $91.2M | 8.56% | 0.51% | -55.6% | Q1 2021 |
 BAX | $86.3M | 8.10% | 0.56% | -50.4% | Q1 2023 |
 HUM | $73.3M | 6.89% | 0.25% | -58.6% | Q2 2013 |
 CVS | $72.4M | 6.80% | 0.08% | -53.3% | Q2 2024 |
 GMED | $47.2M | 4.43% | 0.59% | -36.0% | Q1 2023 |
 ICLR | $43.6M | 4.10% | 0.39% | New | Q2 2025 |
 ASND | $43.2M | 4.05% | 0.41% | -28.6% | Q1 2019 |
 MRK | $39.6M | 3.72% | 0.02% | Not reported | Q4 2013 |
 PFE | $36.4M | 3.41% | 0.03% | -40.0% | Q4 2024 |
 BMRN | $33M | 3.10% | 0.31% | +20.0% | Q3 2021 |
 UNH | $31.2M | 2.93% | 0.01% | Not reported | Q2 2013 |
 VTRS | $24.6M | 2.31% | 0.23% | -63.3% | Q4 2020 |
 BKD | $15M | 1.40% | 0.91% | -65.6% | Q4 2015 |
| ZIMV | $15M | 1.40% | 5.67% | -15.1% | Q1 2022 |
| APLS | $14.7M | 1.38% | 0.67% | New | Q2 2025 |
 MYGN | $10.6M | 1.00% | 2.15% | -14.9% | Q4 2016 |
 EVH | $9.57M | 0.90% | 0.72% | -71.7% | Q1 2022 |
 CON | $8.23M | 0.77% | 0.31% | -75.0% | Q3 2024 |
 INGN | $6.85M | 0.64% | 3.61% | Not reported | Q4 2021 |
 DNLI | $5.6M | 0.53% | 0.27% | -68.0% | Q1 2024 |
| TBPH | $4.96M | 0.47% | 0.89% | -55.0% | Q3 2021 |
 ANAB | $2.78M | 0.26% | 0.45% | -83.3% | Q2 2024 |
 OSUR | $2.7M | 0.25% | 1.22% | Not reported | Q1 2015 |
| Q1 2025 | |||||
| ZBH | $255M | 9.05% | 1.13% | +40.2% | Q1 2021 |
| BAX | $197M | 6.99% | 1.12% | +24.3% | Q1 2023 |
| HUM | $192M | 6.81% | 0.60% | +11.5% | Q2 2013 |
| CVS | $152M | 5.42% | 0.18% | -25.0% | Q2 2024 |
| GMED | $91.5M | 3.25% | 0.91% | +2.0% | Q1 2023 |
 PTCT | $76.4M | 2.72% | 1.89% | -53.1% | Q3 2014 |
 CI | $65.8M | 2.34% | 0.07% | +33.3% | Q2 2015 |
| VTRS | $65.3M | 2.32% | 0.63% | -50.0% | Q4 2020 |
| PFE | $63.4M | 2.25% | 0.04% | -50.0% | Q4 2024 |
 QGEN | $56.2M | 2.00% | 0.63% | -6.7% | Q4 2022 |
| ASND | $54.6M | 1.94% | 0.58% | -56.3% | Q1 2019 |
 SRPT | $51.1M | 1.81% | 0.81% | -20.0% | Q1 2017 |
| BKD | $39.1M | 1.39% | 2.67% | -55.2% | Q4 2015 |
| BMRN | $35.3M | 1.26% | 0.26% | +11.1% | Q3 2021 |
| CON | $34.7M | 1.23% | 1.25% | -54.3% | Q3 2024 |
| EVH | $28.4M | 1.01% | 2.57% | -25.0% | Q1 2022 |
 IONS | $21.9M | 0.78% | 0.46% | +16.0% | Q1 2021 |
| MYGN | $20.8M | 0.74% | 2.55% | -24.2% | Q4 2016 |
| ZIMV | $20.4M | 0.72% | 6.76% | -30.8% | Q1 2022 |
 MLTX | $17.2M | 0.61% | 0.84% | Not reported | Q2 2024 |
| DNLI | $17M | 0.60% | 0.86% | -44.4% | Q1 2024 |
| ANAB | $13.9M | 0.50% | 2.47% | -40.0% | Q2 2024 |
| TBPH | $8.93M | 0.32% | 2.00% | Not reported | Q3 2021 |
 TXG | $8.73M | 0.31% | 0.82% | Not reported | Q4 2024 |
| INGN | $6.95M | 0.25% | 3.63% | -51.3% | Q4 2021 |
 GPCR | $5.19M | 0.18% | 0.17% | Not reported | Q4 2024 |
| OSUR | $3.03M | 0.11% | 1.20% | -78.8% | Q1 2015 |
 GMAB | $979K | 0.03% | Not reported | Not reported | Q1 2024 |
| Q4 2024 | |||||
 MDT | $220M | 5.08% | 0.21% | Not reported | Q1 2022 |
| VTRS | $187M | 4.32% | 1.26% | Not reported | Q4 2020 |
| ZBH | $170M | 3.92% | 0.81% | -35.8% | Q1 2021 |
| HUM | $165M | 3.81% | 0.54% | +225.0% | Q2 2013 |
| PTCT | $144M | 3.34% | 4.12% | -8.6% | Q3 2014 |
 JAZZ | $142M | 3.28% | 1.90% | Not reported | Q4 2023 |
| BAX | $135M | 3.12% | 0.91% | -28.9% | Q1 2023 |
| CVS | $135M | 3.11% | 0.24% | +100.0% | Q2 2024 |
| PFE | $133M | 3.07% | 0.09% | New | Q4 2024 |
| SRPT | $122M | 2.81% | 1.03% | +29.0% | Q1 2017 |
| ASND | $110M | 2.55% | 1.32% | +14.3% | Q1 2019 |
| GMED | $101M | 2.34% | 0.90% | -43.0% | Q1 2023 |
 GSK | $84.6M | 1.96% | 0.06% | -16.7% | Q3 2014 |
| BKD | $70.1M | 1.62% | 6.97% | Not reported | Q4 2015 |
| CON | $69.2M | 1.60% | 2.73% | +77.2% | Q3 2024 |
| QGEN | $66.8M | 1.54% | 0.67% | Not reported | Q4 2022 |
| DNLI | $45.9M | 1.06% | 1.56% | +12.5% | Q1 2024 |
| EVH | $45M | 1.04% | 3.43% | +185.7% | Q1 2022 |
 ALKS | $43.1M | 1.00% | 0.92% | +650.0% | Q2 2016 |
| MYGN | $42.5M | 0.98% | 3.40% | -21.5% | Q4 2016 |
 MEDP | $41.5M | 0.96% | 0.41% | Not reported | Q3 2024 |
| CI | $41.4M | 0.96% | 0.05% | Not reported | Q2 2015 |
| ZIMV | $38M | 0.88% | 9.85% | Not reported | Q1 2022 |
| BMRN | $29.6M | 0.68% | 0.24% | Not reported | Q3 2021 |
| MLTX | $23.9M | 0.55% | 0.84% | Not reported | Q2 2024 |
| IONS | $21.9M | 0.51% | 0.40% | Not reported | Q1 2021 |
 HLF | $20.1M | 0.46% | 2.96% | Not reported | Q1 2023 |
| INGN | $18.3M | 0.42% | 8.37% | Not reported | Q4 2021 |
| ANAB | $16.6M | 0.38% | 4.10% | Not reported | Q2 2024 |
| OSUR | $15.3M | 0.35% | 5.70% | Not reported | Q1 2015 |
| TXG | $14.4M | 0.33% | 0.82% | New | Q4 2024 |
| MRUS | $10.5M | 0.24% | 0.36% | New | Q4 2024 |
| TBPH | $9.41M | 0.22% | 2.02% | Not reported | Q3 2021 |
| GPCR | $8.14M | 0.19% | 0.17% | New | Q4 2024 |
| GMAB | $1.04M | 0.02% | Not reported | Not reported | Q1 2024 |
| Q3 2024 | |||||
| ZBH | $270M | 8.57% | 1.23% | +29.9% | Q1 2021 |
| MDT | $248M | 7.86% | 0.21% | +22.2% | Q1 2022 |
| BAX | $247M | 7.84% | 1.27% | +18.2% | Q1 2023 |
| VTRS | $174M | 5.53% | 1.26% | Not reported | Q4 2020 |
| GMED | $154M | 4.89% | 1.59% | -14.0% | Q1 2023 |
| PTCT | $130M | 4.12% | 4.55% | Not reported | Q3 2014 |
| JAZZ | $128M | 4.07% | 1.86% | Not reported | Q4 2023 |
| GSK | $123M | 3.90% | 0.07% | +12.2% | Q3 2014 |
| MYGN | $108M | 3.44% | 4.34% | -28.2% | Q4 2016 |
| ASND | $105M | 3.32% | 1.21% | Not reported | Q1 2019 |
| SRPT | $96.8M | 3.07% | 0.81% | +416.7% | Q1 2017 |
| BKD | $94.6M | 3.01% | 6.99% | -10.1% | Q4 2015 |
| CVS | $94.3M | 3.00% | 0.12% | Not reported | Q2 2024 |
| SEM | $74.1M | 2.35% | 1.64% | -16.7% | Q1 2015 |
| QGEN | $68.4M | 2.17% | 0.66% | Not reported | Q4 2022 |
| HUM | $63.3M | 2.01% | 0.17% | -50.0% | Q2 2013 |
| DNLI | $58.3M | 1.85% | 1.39% | Not reported | Q1 2024 |
| CON | $44.2M | 1.40% | 1.55% | New | Q3 2024 |
| ZIMV | $43.2M | 1.37% | 9.88% | -16.2% | Q1 2022 |
| MEDP | $41.7M | 1.33% | 0.40% | New | Q3 2024 |
| EVH | $39.6M | 1.26% | 1.20% | +124.0% | Q1 2022 |
 UHS | $28.6M | 0.91% | Not reported | -86.8% | Q2 2013 |
| MLTX | $22.2M | 0.71% | 0.84% | +24.2% | Q2 2024 |
| HLF | $21.6M | 0.69% | 2.98% | Not reported | Q1 2023 |
 BCYC | $20.7M | 0.66% | 1.33% | Not reported | Q3 2023 |
| INGN | $19.4M | 0.62% | 8.40% | Not reported | Q4 2021 |
| OSUR | $18.1M | 0.58% | 5.70% | Not reported | Q1 2015 |
| TBPH | $8.06M | 0.26% | 2.03% | Not reported | Q3 2021 |
| ALKS | $5.6M | 0.18% | 0.12% | Not reported | Q2 2016 |
 SKIN | $2.16M | 0.07% | 1.21% | -57.1% | Q2 2021 |
| GMAB | $1.22M | 0.04% | Not reported | Not reported | Q1 2024 |